Nihal Mohamed, Ph.D. Michael A. Diefenbach, Ph.D. Mount Sinai School of Medicine Department of Urology & Oncological Sciences, New York
|
|
- Paul Dawson
- 6 years ago
- Views:
Transcription
1 Differences between African American and white men in worries and expectations about prostate cancer treatment, need for information, and decisional regret Nihal Mohamed, Ph.D. Michael A. Diefenbach, Ph.D. Mount Sinai School of Medicine Department of Urology & Oncological Sciences, New York
2 Overview Health disparity in prostate cancer & treatment Decisional difficulties & regret Fear of recurrence (FoR) Depressive symptoms Relationship between decisional difficulties, depressive symptoms, FoR, and regret among African American and white patients
3 Prostate Cancer 2008 Pr Ca is the most common cancer effecting men in US & Canada Incidence: 186,320 in US Mortality: 28,660 in US Prostate 25% Lung & bronchus 31% Lung & bronchus 15% Prostate 10% Colon & rectum 10% Colon & rectum 8% Urinary bladder 7% Pancreas 6% Melanoma of skin 5% Leukemia 4% Non-Hodgk lymphoma 5% 4% Kidney 3% Liver & intrahepatic bile duct Oral Cavity 3% Esophagus 4% Leukemia 3% Non-Hodgkin lymphoma 3% Pancreas 2% Urinary bladder 3% Kidney 3% All Other Sites 18% All other sites 21% ACS. Cancer Facts & Figures 2008; FACT SHEET: CANADIAN CANCER STATISTICS CANCER TRENDS ACROSS CANADA & IN BRITISH COLUMBIA
4 Treatment Options of Early stage Prostate Cancer Surgery: Open surgery Laparoscopic Robotic surgery Radiation Therapy: External Beam Radiation therapy Brachytherapy (i.e., Seed Implant) CyberKnife radiosurgery (i.e. Image-guided robotic radiosurgery system) Expectant Management (i.e., Watchful Waiting)?
5 Consequences of Treatment Choice Impaired QOL Sexual Dysfunction Urinary Dysfunction Bowel Dysfunction (Eton & Lepore, 2002; Diefenbach & Mohamed, 2007, 2008)
6 Why prostate cancer treatment decision is so difficult???? Lack of a standard care Contradictions in physicians advices Imperfect data from various studies on QOL (Eton & Lepore, 2002; Diefenbach & Mohamed, 2007)
7 Why prostate cancer treatment decision is so difficult? Trust in the H. C.system Medical Insurance SES Balancing potential benefits of a treatment with the likelihood of impaired QOL & health care burden
8 Health Disparities Health Disparities: Are differences in the incidence, prevalence, mortality and burden of disease and other adverse conditions that exist among specific populations groups in the US. (NIH, 2005) Occur when members of certain population groups do not enjoy the same health status as other groups. Disparities are often identified along racial and ethnic lines-show, [but] also extend beyond race and ethnicity. (NCI, 2005)
9 Health Disparity in Prostate Cancer & treatment African American men: do have the highest incidence rate for prostate cancer in the US are more likely to die of the disease are less likely to undergo radical prostatectomy are more likely to opt for WW than white men. NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.
10 Health Disparity in Prostate Cancer & treatment NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.
11 Health Disparity in Prostate Cancer & treatment NCI (2007). Cancer Health Disparities: Questions and Answers. On-line publication.
12 Cognitive factors affecting prostate cancer treatment decision (Diefenbach & Butz, 2003, Diefenbach & Mohamed, 2007, Diefenbach et al, 2008)
13 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes
14 Study Outline & Referral Sources Physician referral Participant contacted Agree/Decline Participation Baseline Questionnaire 6 months Questionnaire 12 months Questionnaire 18 months Questionnaire 24 months Questionnaire 36 months Questionnaire. Reading St. Mary s North Penn. Pinnacle FCCC Paoli. Jeanes. Co. Delaware.
15 Participants Black White t test /Chi-square p N Age (M±SD) ± ± Marital status: married not married 68.4% 31.6% 84.4% 15.2% <= high school >= College 78.9% 21.1% 78.3% 21.7% Employment: employed Not employed 51.3% 48.7% 40.2% 59.8% Number of DRE s (M±SD) Number of PSA(M±SD) Gleason Score (M±SD) 1.67 ± ± ± ± ± ± Education:
16 Comprehensive Assessments Clinical Variables: Demographics, Medical History Sexual/Urinary Problems Information Sources Treatment Related Psychological Variables: Worry About Treatment Side Effects Distress and Worry about Treatment Decision and Regret Worries about Recurrence Control Preference Scale Treatment Variables: Treatment Questions (Effectiveness) Use of Second Opinions and Recommendations General Psychological Variables: Perceived Vulnerability Affect Scales (i.e., CES-D, RIES) Decisional regret (Brehaut, 2003) Coping (i.e.,mbss) Reasons for Choosing Treatment Quality of Life (i.e., FACT-P)
17 Treatment Related Psychological Variables & Measures Decisional Conflict: Decisional difficulty Need of time Need of information Decisional regret (Brehout & O Conner, 2003) Decision role preferences Control Preferences Scale (Degner et al, 1997) Surgery- and radiation-related beliefs (ad-hoc) Perceived risk and severity of disease (ad-hoc) Worries about cancer recurrence (ad-hoc) Depression scale (CESD; Radloff, 1977)
18 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes
19 Differences between blacks and whites in prostate cancer treatment % Chi-square =.02, p =.99
20 Differences between blacks and whites in prostate cancer related beliefs at baseline Very much Mean * ** Not al all ** p <.01, * p <.05.
21 Differences between blacks and whites treatment-related beliefs at baseline Mean Very much * ** Not al all ** p <.01, * p <.05.
22 Differences between blacks and whites in treatment-related beliefs at baseline Very much Mean *** *** Not al all *** p <.001.
23 Differences between blacks and whites Decision-related beliefs at baseline & 6M Very much Baseline 6 Months Mean * * Not al all * p <.05.
24 Differences between blacks and whites in decision role preferences at baseline % Chi-square = 12.85, p <.01.
25 A. Summary No differences in treatments received by race. Compared to white men, black men: felt less informed about prostate cancer; have stronger beliefs about the severity of the disease; were more worried about surgery causing pain and not curing cancer; were more worried about radiation causing pain and a new cancer; and were more likely to prefer an active role in treatment decision making.
26 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes
27 Results: Decisional regret among blacks and whites at 6M Very much * Not al all * p <.05.
28 Differences between blacks and whites in decisional regret by treatment at 6M Mean Very much Not al all All P <.10
29 Mean Differences between blacks and whites in worries about recurrence by treatment at 6M Very much Not al all F treatment (2, 148) = 4.65, p <.05, Eta-square =.06
30 Results: Depressive symptoms at baseline & 6M % Chi-square =.44, p >.50 Cliff A M, Macdonagh,R.P. Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJUI 68:
31 Study Questions Differences between blacks & whites in: Prostate cancer treatment Beliefs & expectations about treatment Decisional conflict and role preferences Differences between blacks & whites in: Decision-related outcomes (decisional regret, worries about recurrence, and depressive symptoms) Explore Patterns of associations among study outcomes, and Differences between blacks & whites in patters of associations among study outcomes
32 Correlations among cognitive predictors and decision-related outcomes in all patients regardless of race Regret 6M Worries about recurrence 6M Depressive Symptoms 6M Informed about Pr Ca Severity of Pr Ca ***.169* Difficulty of decision ***.205* Need of more time.217**.160*.189* Need of more INFO.393*** *** p <.001, ** p <.01, * p <.05.
33 Differences among blacks & whites in Patterns of associations between decisional conflict and decision-related outcomes Decisional Conflict Beliefs & expectation
34 Associations between study outcomes among black patients depressive symptom. severity E difficulty regret E need of INFO need of time X2 (N =186, df = 12) =6.4, p =.89; NFI =.95, RMSEA =.01 worry E2
35 Associations between study outcomes among white patients depressive symptom. severity E difficulty regret E need of INFO need of time worry X2 (N =186, df = 12) =6.4, p =.89; NFI =.95, RMSEA =.01 E2
36 B. Summary Compared to white men, black men: were more likely to feel regretful about prostate cancer treatment decision. No differences in worries about recurrence and depressive symptoms by race. Among blacks & whites; higher perceived severity of disease was significantly associated with more frequent worries about recurrence. Among blacks; need of time to think about Pr Ca treatment options was significantly associated with stronger feelings of decisional regret.
37 Future Directions Need to: increase prostate cancer literacy of African American men wider implementation of available decisional aids & tools development of culturally tailored educational interventions, care, and training
38 The VCI-S Study on prostate Cancer
39 Thank you for your attention
40 The VCI-S Study on prostate Cancer
41 Results: Depressive Symptoms over time by race
42 Results: Depressive symptoms by treatment & race
43 Worries about cancer recurrence at 6M 2-item scale How worried are you that prostate cancer will recur? How worried are you that prostate cancer might spread? Not at all (1) (5) very much Inter-item correlation was r =.82 (p <.001).
44 Differences among blacks & whites in Patterns of associations among study outcomes
Epidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More informationCancer Facts & Figures for African Americans
Cancer Facts & Figures for African Americans What is the Impact of Cancer on African Americans in Indiana? Table 12. Burden of Cancer among African Americans Indiana, 2004 2008 Average number of cases
More informationEvaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO
More informationPROSTATE CANCER Amit Gupta MD MPH
PROSTATE CANCER Amit Gupta MD MPH Depts. of Urology and Epidemiology Amit-Gupta-1@uiowa.edu dramitgupta@gmail.com Tel: 319-384-5251 OUTLINE PSA screening controversy How to use PSA more effectively Treatment
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT
Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want
More informationConstruction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationB.S (Honor) Psychology. University of Khartoum, Sudan, Diploma Cancer Prevention. The National Cancer Institute, USA, 2006.
Nihal E. Mohamed Office Address: The Mount Sinai Hospital Mount Sinai School of Medicine Department of Urology One Gustave L Levy Place Box 1272 New York NY 10029-6574 Tel.: 212-741-8858 Fax: 212-879-3246
More informationAchieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016
Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationHIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA
HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA The prostate is a small gland the size of a walnut which produces fluid to protect and lubricate the sperm It
More informationThe Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012
The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2014 334 Jefferson Avenue, Scranton,
More informationNational Cancer Statistics in Korea, 2014
National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored
More informationCancer A Superficial Introduction
Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2018 334 Jefferson Avenue, Scranton,
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,
More information2016 Oncology Institute Annual Report
2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual
More informationTHE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA
THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry
More informationPROSTATE CANCER CONTENT CREATED BY. Learn more at
PROSTATE CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents Ask your doctor about screening and treatment options. WHAT IS PROSTATE CANCER? 4 WATCHFUL
More informationThe Selenium and Vitamin E Prevention Trial
The largest-ever-prostate cancer prevention trial is now underway. The study will include a total of 32,400 men and is sponsored by the National Cancer Institute and a network of researchers known as the
More informationCancer in New Mexico 2014
Cancer in New Mexico 2014 Please contact us! Phone: 505-272-5541 E-Mail: info@nmtr.unm.edu http://som.unm.edu/nmtr/ TABLE OF CONTENTS Introduction... 1 New Cases of Cancer: Estimated Number of New Cancer
More informationCancer Dispari,es in Indiana
Cancer Dispari,es in Indiana Susan M. Rawl, PhD, RN, FAAHB, FAAN Professor, Indiana University School of Nursing Co- Leader, Cancer PrevenEon & Control Program Indiana University Simon Cancer Center Indiana
More informationObjectives. Introduction. Questions???? Basic Facts. More Questions??? Treatment Decision Making in Prostate Cancer: Choices, Chances and Challenges
Treatment Decision Making in Prostate Cancer: Choices, Chances and Challenges Anne Katz, RN, PhD Mary Schoen, RN, MSN, MPH, ANP, OCN Objectives Describe treatment choices for men newly diagnosed with prostate
More informationColorectal Cancer Screening
Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program
More informationDr Sylvie Lambert, RN, PhD
Is it the most frequent unmet supportive care needs that predict caregivers anxiety and depression? Results from Australia s Partners and Caregivers Longitudinal Well-being Study Dr Sylvie Lambert, RN,
More informationCancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer
Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more
More informationContemporary Approaches to Screening for Prostate Cancer
Contemporary Approaches to Screening for Prostate Cancer Gerald L. Andriole, MD Robert K. Royce Distinguished Professor Chief of Urologic Surgery Siteman Cancer Center Washington University School of Medicine
More informationAllinaHealthSystems 1
2018 Dimensions in Oncology Genitourinary Cancer Disclosures I have no financial or commercial relationships relevant to this presentation. Matthew O Shaughnessy, MD, PhD Director of Urologic Oncology
More informationProstate cancer. Treatments Side effects and management in the community setting
Prostate cancer Treatments Side effects and management in the community setting Kristoffer Ohlin CNS Urology Janice Minter Lead Cancer Nurse St George s Hospital Agenda Prostate cancer treatments Radiotherapy
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationQuality of Life After Modern Treatment Options for Prostate Cancer Ronald Chen, MD, MPH
Quality of Life After Modern Treatment Options I will be presenting some recently published data on the quality of life after modern treatment options for prostate cancer. My name is Dr. Ronald Chen. I'm
More informationBioengineering and World Health. Lecture Twelve
Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How
More informationCancer in New Mexico 2017
Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description
More informationBurden of Cancer in California
Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality
More informationThe Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin
The Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin A prostate care coordinator supports, educates, and guides patients through diagnosis, treatment, and follow-up by Don Jewler
More informationNEZ PERCE COUNTY CANCER PROFILE
NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationKOOTENAI COUNTY CANCER PROFILE
KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationBOUNDARY COUNTY CANCER PROFILE
BOUNDARY COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationSamuel M. Lesko, MD, MPH Director of Research/Medical Director
Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984
More informationADAMS COUNTY CANCER PROFILE
ADAMS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group
More informationBONNER COUNTY CANCER PROFILE
BONNER COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2010-2014 Cancer Mortality 2011-2015 BRFSS 2011-2015 CANCER Cancer is a group
More informationBINGHAM COUNTY CANCER PROFILE
BINGHAM COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationNICE BULLETIN Diagnosis & treatment of prostate cancer
Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationConsensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director
BASIS FOR FURHTER STUDIES Main controversies In prostate Cancer: 1-Screening 2-Management Observation Surgery Standard Laparoscopic Robotic Radiation: (no discussion on Cryosurgery-RF etc.) Standard SBRT
More informationNEZ PERCE COUNTY CANCER PROFILE
NEZ PERCE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a
More informationKOOTENAI COUNTY CANCER PROFILE
KOOTENAI COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationTWIN FALLS COUNTY CANCER PROFILE
TWIN FALLS COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is
More informationThe Role Primary Care has in Reducing Prostate Cancer Disparities
The Role Primary Care has in Reducing Prostate Cancer Disparities Paul Monk Associate Professor Clinical Division of Medical Oncology Ohio State University Prostate Cancer Disparity Does it exist? Prostate
More informationAbout the authors Dr S. Larry Goldenberg Dr Tom Pickles Dr Kim N. Chi
Authors S. Larry Goldenberg, CM, OBC, MD, FRCSC, FCAHS Professor and Head, University of British Columbia Department of Urologic Sciences, Stephen A. Jarislowski Chair in Urologic Sciences at Vancouver
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More informationJEROME COUNTY CANCER PROFILE
JEROME COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationBUTTE COUNTY CANCER PROFILE
BUTTE COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationLINCOLN COUNTY CANCER PROFILE
LINCOLN COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationLocally advanced prostate cancer
Diagnosis Helpline 0800 074 8383 prostatecanceruk.org 1 Locally advanced prostate cancer In this fact sheet: What is locally advanced prostate cancer? What tests are used to diagnose locally advanced prostate
More informationCANYON COUNTY CANCER PROFILE
CANYON COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group
More informationFactors Associated with Initial Treatment for Clinically Localized Prostate Cancer
Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Preliminary Results from the National Program of Cancer Registries Patterns of Care Study (PoC1) NAACCR Annual Meeting
More informationBrachytherapy Treatment of Prostate Cancer: a Post- Operative Case Study
Brachytherapy Treatment of Prostate Cancer: a Post- Operative Case Study Kyle N. Dawson Freeport High School, Freeport NY USA 11520 Abstract. When prostate cancer is detected, a common and often successful
More informationNIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.
NIH Public Access Author Manuscript Published in final edited form as: Cancer. 2005 December 15; 104(12 Suppl): 2989 2998. 1999 2001 Cancer Mortality Rates for Asian and Pacific Islander Ethnic Groups
More informationTHE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES
THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES OVERVIEW Diagnosis Laboratory Tests PSA Free and Total PSA PCA-3 4K Score The
More informationCancer Institute. cancer institute Program overview Report 2013
Cancer Institute cancer institute Program overview Report 2013 Saint Francis Medical Center in Cape Girardeau, Mo., is a regional leader in the battle against cancer, bringing new techniques, ideas and
More informationResearching Genetic Influences in Different Racial/Ethnic Populations and Cancer
Researching Genetic Influences in Different Racial/Ethnic Populations and Cancer Lenora WM Loo, PhD Assistant Professor (Specialist) University of Hawaii Cancer Center Off-Label Use Disclosure I do not
More informationRobotic Surgery for Prostate Cancer: A Realistic Approach to Getting Started The Evolution of a Robotic Surgeon
Robotic Surgery for Prostate Cancer: A Realistic Approach to Getting Started The Evolution of a Robotic Surgeon Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College of Cornell
More informationProstate Cancer Dashboard
Process Risk Assessment Risk assessment: family history assessment of family history of prostate cancer Best Observed: 97 %1 ; Ideal Benchmark:100% measure P8 2 Process Appropriateness of Care Pre-treatment
More informationCancer Disparities in Arkansas: An Uneven Distribution. Prepared by: Martha M. Phillips, PhD, MPH, MBA. For the Arkansas Cancer Coalition
Cancer Disparities in Arkansas: An Uneven Distribution Prepared by: Martha M. Phillips, PhD, MPH, MBA For the Arkansas Cancer Coalition Table of Contents Page Burden of Cancer 3 Cancer Disparities 3 Cost
More informationCancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014
Cancer in Rural Illinois, 1990-2010 Incidence, Mortality, Staging, and Access to Care April 2014 Prepared by Whitney E. Zahnd, MS Research Development Coordinator Center for Clinical Research Southern
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationProstate Overview Quiz
Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the
More informationAn Overview of Disparities Research in Access to Radiation Oncology Care
An Overview of Disparities Research in Access to Radiation Oncology Care Shearwood McClelland III, M.D. Department of Radiation Medicine Oregon Health & Science University Portland, Oregon Disclosures
More informationActive surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation
Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation Alice Dragomir, PhD Fabio Cury, MD Armen Aprikian, MD Introduction Clinical and economic burden
More informationObjectives. Men s Health in US. Gender as a determinant of health status. Gender and racial differences in life expectancy, US
Objectives Determinants of Men s Health: Opportunities for Evidence-based intervention Jean G. Ford, M.D. Department of Epidemiology Johns Hopkins Bloomberg of Public Health Baltimore, MD Epidemiologic
More informationJennifer Fournier, RN MSN AOCN CHPN on 6/16/2012 at Oncology Nursing Society
SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,
More informationPublic Reporting of Outcomes CANCERCARE CENTER
Public Reporting of Outcomes CENTER Minot, North Dakota 206 TRINITY HEALTH STATISTICS 206 There are,790 cancer primaries in the Trinity Health cancer registry from 990 (assession year) through 206. This
More informationPREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA
PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA CINA SURVIVAL Authors: Chris Johnson, Deborah Hurley, Angela Mariotto, Reda Wilson, Donna Turner, Hannah
More informationImproving Women s Health in South Carolina Best Chance Network and WISEWOMAN. Dr. Trenessa K. Jones Best Chance Network Program Director
Improving Women s Health in South Carolina Best Chance Network and WISEWOMAN Dr. Trenessa K. Jones Best Chance Network Program Director Presentation Objectives Overview the History and Need for the Best
More informationMr PHIP No. 1 Prostate cancer: Should I be tested?
Mr PHIP No. 1 cancer: Should I be tested? Having a large prostate doesn t increase your chances of having prostate cancer. No. 1 / 1 Key points cancer is the most common male cancer after skin cancer.
More informationRECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK
02 April, 2018 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK Document Filetype: PDF 501.52 KB 0 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK If you have been diagnosed with prostate
More informationWhen to worry, when to test?
Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October
More informationQuestions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test
Questions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test About Cancer Care Ontario s recommendations for prostate-specific antigen (PSA) screening 1. What does Cancer
More informationYour Guide to Prostate Cancer
Your Guide to Prostate Cancer If you face a diagnosis of prostate cancer, what s next? We can help. A prostate cancer diagnosis can be overwhelming. The good news is that while prostate cancer can be serious,
More informationThe Prostate Cancer Surgery Tick List. Use these questions as starters for your first meeting with your prostate cancer surgeon.
The Prostate Cancer Surgery Tick List Use these questions as starters for your first meeting with your prostate cancer surgeon. Print these out and had to your doctor at the start of your meeting. Tick
More informationUnderstanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD
Understanding the risk of recurrence after primary treatment for prostate cancer Aditya Bagrodia, MD Aditya.bagrodia@utsouthwestern.edu 423-967-5848 Outline and objectives Prostate cancer demographics
More informationProstate Cancer: from Beginning to End
Prostate Cancer: from Beginning to End Matthew D. Katz, M.D. Assistant Professor Urologic Oncology Robotic and Laparoscopic Surgery University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer
More informationPros and Cons from the Patient Perspective in the Three Phases
Pros and Cons from the Patient Perspective in the Three Phases Wanda M. Burdette, RN, OCN, CCRP Spartanburg Regional Medical Center SCOR NCORP November 6, 2015 12:00-2:00 PM CT Presentation Objectives
More informationCommunities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA
Communities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA Marjorie Kagawa Singer, Ph.D., M.N., M.A., R.N. UCLA School of Public Health and Asian American Studies Center
More informationThis report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance
This report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance goes to: Stephanie Pike, MPH Public Health Specialist
More informationScreening and Diagnosis Prostate Cancer
Screening and Diagnosis Prostate Cancer Daniel Heng MD MPH FRCPC Chair, Genitourinary Tumor Group Tom Baker Cancer Center University of Calgary, Canada @DrDanielHeng Outline Screening Evidence Recommendations
More informationTHE UROLOGY GROUP
THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,
More informationCancer Statistics, 2008
CA Cancer J Clin 8;58:71 96 Cancer Statistics, 8 Ahmedin Jemal, DVM, PhD; Rebecca Siegel, MPH; Elizabeth Ward, PhD; Yongping Hao, PhD; Jiaquan Xu*, MD; Taylor Murray; Michael J. Thun, MD, MS ABSTRACT Each
More information